Evidence map›Paper›PMID 39154004›Full record

ArticleBMC geriatrics2024

Mapping the evidence on dementia care pathways - A scoping review.

Marianne Saragosa, Evan MacEachern, Mary Chiu, Sean Weylie, Krista Schneider, Elaine R Maloney, Jordanne Holland, Kerry Kuluski, Ani Orchanian-Cheff, Michelle LA Nelson

Abstract readScoping Review
In one paragraph

Article in BMC geriatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Time to Diagnosis in Dementia: A Systematic Review With Meta-Analysis.International journal of geriatric psychiatry · 2025
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marianne SaragosaScience of Care Institute, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M4M 2B5, Canada. Marianne.Saragosa@sinaihealth.ca.
Evan MacEachernScience of Care Institute, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M4M 2B5, Canada.
Mary ChiuOntario Shores Centre for Mental Health Science, Whitby, ON, L1N 5S9, Canada.
Sean WeylieAlzheimer Society Peel, Mississauga, ON, L5G 3N6, Canada.
Krista SchneiderAlzheimer Society of Chatham-Kent, Chatham, ON, N7L 5M8, Canada.
Elaine R MaloneyFamily Caregiver, Ontario, Canada.
Jordanne HollandCentre for Addiction and Mental Health, Toronto, ON, M6J 1H4, Canada.
Kerry KuluskiTrillium Health Partners, Mississauga, ON, L5B 1B8, Canada.
Ani Orchanian-CheffLibrary and Information Services, University Health Network, Toronto, ON, M5G 2C4, Canada.
Michelle LA NelsonScience of Care Institute, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M4M 2B5, Canada.

Funding

Alzheimer Society 0000000008
6 · The paper itself

Abstract

backgroundOne way of standardizing practice and improving patient safety is by introducing clinical care pathways; however, such pathways are typically geared towards assisting clinicians and healthcare organizations with evidence-based practice. Many dementia care pathways exist with no agreed-upon version of a care pathway and with little data on experiences about their use or outcomes. The objectives of the review were: (1) to identify the dementia care pathway's purpose, methods used to deploy the pathway, and expected user types; (2) to identify the care pathway's core components, expected outcomes, and implications for persons with dementia and their care partners; and (3) determine the extent of involvement by persons with dementia and/or their care partners in developing, implementing, and evaluating the care pathways.

methodsWe systematically searched six literature databases for published literature in the English language in September 2023 utilizing Arskey and O'Malley's scoping review framework.

resultsThe findings from the dementia care pathways (n = 13) demonstrated assistance in dementia diagnostic and management practices for clinicians and offered structured care processes in clinical settings. For this reason, these pathways emphasized assessment and interventional post-diagnostic support, with less emphasis on community-based integrated dementia care.

conclusionFuture dementia care pathway development can seek the involvement of persons with dementia and care partners in designing, implementing and evaluating such pathways, ensuring that outcome measures properly reflect the impact on persons with lived dementia experience and their care partners.

Indexed as

Critical PathwaysDementiaHumansCare partnerCare pathwayDementiaPatient engagementPerson-centredScoping review

Identifiers

PMID39154004
PMCPMC11330604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.